Published in J Clin Oncol on March 29, 2010
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Mol Cancer (2010) 1.10
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma. Oncogene (2012) 1.01
Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma. J Pediatr Hematol Oncol (2015) 0.91
Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients. BMC Bioinformatics (2013) 0.89
High genomic instability predicts survival in metastatic high-risk neuroblastoma. Neoplasia (2012) 0.89
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome. BMC Bioinformatics (2012) 0.89
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era. Cancer (2014) 0.89
Population-based survival estimates for childhood cancer in Australia during the period 1997-2006. Br J Cancer (2010) 0.87
Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients. BMC Bioinformatics (2014) 0.85
Plasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patients. Biomed Res Int (2013) 0.84
Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice. Dis Model Mech (2015) 0.83
Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma. Onco Targets Ther (2012) 0.81
Laparoscopic resection of adrenal neuroblastoma without image-defined risk factors: a prospective study on 21 consecutive pediatric patients. Pediatr Surg Int (2014) 0.80
Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients. Oncotarget (2015) 0.79
IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome. J Immunol Res (2015) 0.78
Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm. BMC Med Genomics (2015) 0.77
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma. J Transl Med (2016) 0.76
A single center clinical analysis of children with neuroblastoma. Oncol Lett (2015) 0.76
MDA5 complements TLR3 in suppression of neuroblastoma. Oncotarget (2015) 0.76
Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. Am J Pathol (2016) 0.75
Hypoxia alters the recruitment of tropomyosins into the actin stress fibres of neuroblastoma cells. BMC Cancer (2015) 0.75
Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival. Biomed Res Int (2015) 0.75
Epidemiological and clinical characteristics of neuroblastoma in southern iran. Iran J Ped Hematol Oncol (2014) 0.75
Artificial neural network classifier predicts neuroblastoma patients' outcome. BMC Bioinformatics (2016) 0.75
Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis? BMC Cancer (2017) 0.75
Neuroblastoma presenting with symptoms of epidural compression at birth: a case report. Ital J Pediatr (2016) 0.75
Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma. Oncotarget (2017) 0.75
Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015. Paediatr Drugs (2017) 0.75
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol (2008) 6.66
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol (2002) 3.53
Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int (2009) 3.13
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol (2009) 3.07
Second-look surgery for ependymoma: the Italian experience. J Neurosurg Pediatr (2011) 2.12
Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer (2009) 2.08
Kikuchi-Fujimoto disease is a rare cause of lymphadenopathy and fever of unknown origin in children: report of two cases and review of the literature. J Pediatr Hematol Oncol (2005) 2.03
The Youth Project at the Istituto Nazionale Tumori in Milan. Tumori (2012) 1.98
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A (2004) 1.91
Pancreatic tumors in children and adolescents: the Italian TREP project experience. Pediatr Blood Cancer (2010) 1.80
Patterns of domestic migrations and access to childhood cancer care centres in Italy: a report from the hospital based registry of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Eur J Cancer (2008) 1.73
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica (2010) 1.68
Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol (2005) 1.66
Tumor origin of endothelial cells in human neuroblastoma. J Clin Oncol (2007) 1.62
Kabuki syndrome and cancer in two patients. Am J Med Genet A (2010) 1.62
Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol (2005) 1.61
Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants. Cancer Chemother Pharmacol (2011) 1.56
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia (2004) 1.56
A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood (2005) 1.54
Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project. Pediatr Blood Cancer (2008) 1.52
Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: feasibility and efficacy in refractory pediatric sarcoma. Pediatr Blood Cancer (2010) 1.50
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res (2003) 1.50
Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967-2001. A report of the Childhood Cancer Registry of Piedmont. Haematologica (2005) 1.48
Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer (2009) 1.48
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol (2003) 1.47
Reactivation of Chagas disease after a bone marrow transplant in Italy: first case report. Blood Transfus (2012) 1.46
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. Eur J Nucl Med Mol Imaging (2011) 1.46
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol (2002) 1.45
Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan. Clin Nucl Med (2014) 1.45
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res (2003) 1.45
Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry. Eur J Cancer (2009) 1.44
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients. Cancer Res (2009) 1.41
MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma. Pediatr Blood Cancer (2010) 1.40
Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer (2006) 1.35
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood (2002) 1.34
Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst (2007) 1.34
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project. Eur J Cancer (2010) 1.30
Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer (2009) 1.29
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. Blood (2013) 1.29
Multimodality imaging of Hodgkin disease and non-Hodgkin lymphomas in children. Radiographics (2007) 1.28
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol (2009) 1.27
Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee. Cancer (2006) 1.27
Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J (2006) 1.25
Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group. Cancer (2003) 1.25
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. Clin Cancer Res (2009) 1.24
Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer (2006) 1.22
Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer (2010) 1.22
Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol (2007) 1.20
Neuroblastoma in adolescents: the Italian experience. Cancer (2006) 1.19
Mechanisms of immune evasion of human neuroblastoma. Cancer Lett (2005) 1.17
Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer (2005) 1.16
Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet (2008) 1.13
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene (2005) 1.13
Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. J Clin Oncol (2009) 1.13
Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP). Haematologica (2008) 1.12
Seasonal changes in mortality rates from main causes of death in Japan (1970--1999). Eur J Epidemiol (2004) 1.11
Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer (2006) 1.10
Biosimilar granulocyte-colony-stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology-oncology patients. Transfusion (2014) 1.10
Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol (2011) 1.10
Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer (2007) 1.09
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol (2008) 1.09
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol (2010) 1.09
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. Cancer Immunol Immunother (2007) 1.07
Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors. Int J Radiat Oncol Biol Phys (2007) 1.06
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol (2002) 1.06
Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials. Eur J Cancer (2009) 1.06
The natural history of Cri du Chat Syndrome. A report from the Italian Register. Eur J Med Genet (2006) 1.05
Adult Wilms' tumor: A monoinstitutional experience and a review of the literature. Cancer (2004) 1.05
Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol (2005) 1.05
Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies. Cancer (2010) 1.04
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. Cancer Lett (2005) 1.04
Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins. PLoS One (2012) 1.03
Medulloblastoma in young children. Pediatr Blood Cancer (2010) 1.03
Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP). Eur J Cancer (2008) 1.03